Skip to content

the efficacy and safety in children following 650 nm red-light therapy for myopia control

the efficacy and safety in children following 650 nm red-light therapy for myopia control

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090938
Enrollment
Unknown
Registered
2024-10-16
Start date
2021-10-10
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

RLRL group:650 nm red-light therapy
control group:none

Sponsors

Children's Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1) Children aged 7-12 years old. 2) Children with pre-myopia or mild myopia.

Exclusion criteria

Exclusion criteria: 1) Participated in any myopia control clinical research trial within 3 months, used or is currently using multifocal contact lenses, atropine drugs, etc.; 2) Children with strabismus and amblyopia; 3) Congenital eye diseases, such as congenital cataracts and congenital retinal diseases; 4) Secondary myopia (such as secondary myopia caused by retinopathy of prematurity or other infant eye diseases), or myopia combined with systemic syndromes (such as Marfan syndrome); 5) People who have undergone myopia correction (such as LASIK, etc.), internal eye surgery (such as cataract extraction, intraocular lens implantation, etc.); 6) refractive media turbidity (such as keratopathy, crystal turbidity, etc.) 7) Abnormal IOP (IOP 21mmHg or binocular IOP asymmetry =5mmHg); 8) Patients with fundus retinopathy or other intraocular diseases; 9) Patients with optic nerve damage or congenital optic nerve dysfunction; 10) Have systemic diseases that may affect the eyes, such as diabetes, Down syndrome, hyperthyroidism, etc; 11) Only one eye meets the inclusion criteria; 12) Those who cannot regularly (or the guardian cannot regularly accompany the children) carry out eye examination; 13) Other reasons that the doctor considers unsuitable for inclusion in the program.

Design outcomes

Primary

MeasureTime frame
axial length;

Secondary

MeasureTime frame
spherical equivalent refraction; subfoveal choroidal thickness;

Countries

China

Contacts

Public ContactChenhao Yang

Children's Hospital of Fudan University

ychben@hotmail.com+86 21 6493 1913

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026